Verrica Pharmaceuticals Inc. (VRCA) Stock

Healthcare · Biotechnology · Member of Other US Stocks

Verrica Pharmaceuticals Inc. (VRCA) closed at USD 3.83 on 2026-10-14, a change of +5.8 % over the past year, with a market capitalization of USD 64.94M.

Verrica Pharmaceuticals Inc. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Verrica Pharmaceuticals Inc. key figures

Previous close

USD 3.83 (2026-10-14)

1-year change

+5.8 %

Market cap

USD 64.94M

Enterprise value

USD 55.55M

P/E ratio (trailing)

-2.01

P/E ratio (forward)

-2.56

EPS (trailing)

-1.88

EPS (forward)

-1.48

PEG ratio

n/a

Price to book

15.06

Revenue growth

-53.9 %

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

3.79

Employees

76

Analyst consensus (third-party)

strong_buy

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Verrica Pharmaceuticals Inc.

Verrica Pharmaceuticals Inc., a dermatology therapeutics company, engages in the development and commercialization of medications for the treatment of dermatologic diseases in the United States. The company offers YCANTH (VP-102) a drug-device combination that contains a GMP-controlled formulation of cantharidin for the treatment of molluscum in adult and pediatric patients, as well as for the treatment of common warts. It also develops VP-315, an oncolytic peptide-based injectable therapy that is in phase II clinical trial for the treatment of dermatology oncologic conditions, which include basal cell carcinoma and other dermatological oncology indications. The company has a collaboration and license agreement with Torii Pharmaceutical Co., Ltd. for the development and commercialization of its product candidates for the treatment of molluscum and common warts in Japan; and a license agreement with Lytix Biopharma AS to develop and commercialize VP-315 for use in malignant and pre-malignant dermatological indications. Verrica Pharmaceuticals Inc. was incorporated in 2013 and is headquartered in West Chester, Pennsylvania.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Verrica Pharmaceuticals Inc. and compare it with other stocks.